Issued Patents All Time
Showing 1–22 of 22 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10202658 | Methods for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors | Eoin Coakley | 2019-02-12 |
| 9841425 | Methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays | Douglas Richman, Mary T. Wrin, Susan Little, Christos J. Petropoulos, Jeannette Whitcomb +1 more | 2017-12-12 |
| 9175355 | Methods for determining the presence of antibodies blocking viral infection | Douglas Richman, Mary T. Wrin, Susan Little, Christos J. Petropoulos, Jeannette Whitcomb +1 more | 2015-11-03 |
| 8637252 | Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs | Soumi Gupta, Signe Fransen, Ellen Paxinos | 2014-01-28 |
| 8178291 | Methods and compositions for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors | Eoin Coakley | 2012-05-15 |
| 8071284 | Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs | Soumi Gupta, Signe Fransen, Ellen Paxinos | 2011-12-06 |
| 7993824 | Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors | Colombe Chappey, Christos J. Petropoulos | 2011-08-09 |
| 7553618 | Method for determining human immunodeficiciency virus type 1 (HIV-1) hypersusceptibility to the protease inhibitor amprenavir | Ellen Paxinos, Colombe Chappey, Mary T. Wrin, Andrea Gamarnik, Christos J. Petropoulos | 2009-06-30 |
| 7384734 | Compositions and methods for determining the susceptibility of a pathogenic virus to protease inhibitors | Colombe Chappey, Christos J. Petropoulos | 2008-06-10 |
| 7247439 | Method of evaluating a patient antibody response to envelope proteins of a virus | Douglas Richman, Mary T. Wrin, Susan Little, Christos J. Petropoulos, Jeannette Whitcomb +1 more | 2007-07-24 |
| 7235356 | Methods of evaluating cell surface receptor binding of a patient derived population of viral envelope protein constructs | Christos J. Petropoulos, Jeanette Whitcomb, Wei Huang | 2007-06-26 |
| 7186506 | Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS | Rainer Ziermann | 2007-03-06 |
| 7169551 | Methods of evaluating viral entry inhibitors using patient derived envelope protein constructs | Christos J. Petropoulos, Jeanette Whitcomb, Wei Huang | 2007-01-30 |
| 7138231 | Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS | Rainer Ziermann | 2006-11-21 |
| 7097970 | Methods of evaluating viral entry inhibitors using patient derived envelope protein constructs | Christos J. Petropoulos, Jeanette Whitcomb, Wei Huang | 2006-08-29 |
| 6974686 | Recombinant tryptophan mutants of influenza | — | 2005-12-13 |
| 6869759 | Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS | Rainer Ziermann | 2005-03-22 |
| 6843996 | Immunogenic composition comprising an influenza virus with a temperature sensitive PB2 mutation | Kathleen L. Coelingh | 2005-01-18 |
| 6528064 | Recombinant trytophan mutants of influenza | — | 2003-03-04 |
| 6322967 | Recombinant tryptophan mutants of influenza | — | 2001-11-27 |
| 6090391 | Recombinant tryptophan mutants of influenza | — | 2000-07-18 |
| 5690937 | Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene | Kathleen L. Coelingh | 1997-11-25 |